恩捷股份(002812.SZ):10噸級硫化物固態電解質已經建成,具備供貨能力,目前尚未能產生規模化的收入
格隆匯8月13日丨恩捷股份(002812.SZ)在互動平台表示,在全固態電池材料佈局方面,公司下屬控股子公司湖南恩捷前沿新材料科技有限公司專注高純硫化鋰、硫化物固態電解質和硫化物固態電解質膜產品的研發和佈局,高純硫化鋰產品的百噸級硫化鋰中試線已經搭建完成,10噸級硫化物固態電解質已經建成,具備供貨能力,目前尚未能產生規模化的收入。公司將繼續投入研發,積極開拓市場,加深與客户的合作和技術交流,推動行業技術發展。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.